AI-powered
podcast player
Listen to all your favourite podcasts with AI-powered features
Addressing Itch in CKD: The HSK21542 Trial
This chapter explores the clinical trial of HSK21542, a kappa opioid agonist, aimed at alleviating itch in chronic kidney disease patients undergoing dialysis. It underscores the importance of addressing pruritus to enhance patient quality of life while examining the challenges and efficacy of new treatment options.